RBC Capital Oracle · ORCL

RBC Capital Lowers Oracle Price Target to $195

Analyst: Rishi Jaluria 1 min read Reproduced verbatim
Rating
Unknown
Target
$195
from $250 (−22%)
Outcome
Reached
on January 5, 2026
RBC Capital and Oracle logos

What the analyst said

RBC Capital analyst Rishi Jaluria lowered the price target on Oracle (NYSE: ORCL) to $195.00 (from $250.00).

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $115. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $195 target is 16% below the median.

Since the note ORCL has moved −41% (from $196). 12-month window: day 304 of 365, closes on January 5, 2027.

Track record

This call✓ Target reached on January 5, 2026, 0 days after the note.

Firm track recordRBC Capital: 47% of its 17 targets at least a year old were reached within 12 months (#26 of 26 firms). Accuracy ranking →

RBC Capital on Oracle

RBC Capital price targets on Oracle

6 calls from January 5, 2026 to September 11, 2026. The target went from $195 to $165 (−15%). The rating stayed Hold.

RBC Capital targetORCL share price
  1. September 11, 2026Target cut from $190 (−13%)Hold$165
  2. June 11, 2026Kept the $190 targetHold$190
  3. June 4, 2026Target raised from $160 (+19%)Hold$190
  4. March 11, 2026Kept the $160 targetHold$160
  5. March 4, 2026Target cut from $195 (−18%)Hold$160
  6. January 5, 2026 This noteEarliest call shown$195
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.